344 related articles for article (PubMed ID: 6319491)
1. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
2. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function.
Roszman TL; Brooks WH; Steele C; Elliott LH
J Immunol; 1985 Mar; 134(3):1545-50. PubMed ID: 3155771
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.
Elliott L; Brooks W; Roszman T
J Natl Cancer Inst; 1987 May; 78(5):919-22. PubMed ID: 3106694
[TBL] [Abstract][Full Text] [Related]
4. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes.
Miescher S; Whiteside TL; Carrel S; von Fliedner V
J Immunol; 1986 Mar; 136(5):1899-907. PubMed ID: 2936812
[TBL] [Abstract][Full Text] [Related]
5. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
6. Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.
Roszman TL; Brooks WH
Clin Exp Immunol; 1980 Feb; 39(2):395-402. PubMed ID: 6966992
[TBL] [Abstract][Full Text] [Related]
7. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
[TBL] [Abstract][Full Text] [Related]
8. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
9. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
10. Human bone marrow allograft recipients: production of, and responsiveness to, interleukin 2.
Warren HS; Atkinson K; Pembrey RG; Biggs JC
J Immunol; 1983 Oct; 131(4):1771-5. PubMed ID: 6352802
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
Braun DP; Penn RD; Flannery AM; Harris JE
Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
[TBL] [Abstract][Full Text] [Related]
13. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 activity and the response of peripheral blood lymphocytes in patients with gynecologic malignancies.
Iwano I; Kikuchi Y; Oomori K; Kizawa I; Kita T; Kato K
Cancer Detect Prev; 1988; 12(1-6):583-8. PubMed ID: 3263201
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
Yamaguchi E
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
[TBL] [Abstract][Full Text] [Related]
16. Early biochemical events associated with lymphocyte activation in ageing. I. Evidence that Ca2+ dependent processes induced by PHA are impaired.
Kennes B; Hubert C; Brohee D; Neve P
Immunology; 1981 Jan; 42(1):119-26. PubMed ID: 6780450
[TBL] [Abstract][Full Text] [Related]
17. Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
Gluckman JC; Klatzmann D; Cavaille-Coll M; Brisson E; Messiah A; Lachiver D; Rozenbaum W
Clin Exp Immunol; 1985 Apr; 60(1):8-16. PubMed ID: 3924452
[TBL] [Abstract][Full Text] [Related]
18. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 inhibits the generation of phytohemagglutinin-activated killer activity in human peripheral blood lymphocytes.
Yamashita N; Ito M; Suzuki H; Sugiyama E; Yokoyama A; Sato M; Yano S
Anticancer Res; 1986; 6(5):1113-6. PubMed ID: 3492171
[TBL] [Abstract][Full Text] [Related]
20. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
